TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01495637 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03679273 — Predictive Biomarker (PRD): FOXA2 mRNA
Genes: FOXA2; HNF3B; TCF3B
Study NCT04140058 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00363402 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03803033 — Predictive Biomarker (PRD): HMMR mRNA
Genes: HMMR; IHABP; RHAMM
Study NCT04470531 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04661826 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00597259 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03389256 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03389256 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03893435 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05712642 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02329119 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT00578903 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00122356 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00122356 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00901355 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05266261 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03421444 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03421444 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03421444 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00002833 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01132664 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03118180 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01239472 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01828658 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03059667 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03059667 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03059667 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT01302899 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00077376 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01497626 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01497626 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04132505 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03969329 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT04160195 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01561443 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04297020 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01827059 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00604201 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00202397 — Predictive Biomarker (PRD): DCN mRNA
Genes: DCN; SLRR1B
Study NCT00202397 — Predictive Biomarker (PRD): KCNN1 mRNA
Genes: KCNN1; SK
Study NCT02116517 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00442754 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03447886 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03447886 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03166865 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00737737 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03074864 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01588860 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02658916 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00266240 — Predictive Biomarker (PRD): GK mRNA
Genes: GK
Study NCT03173170 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00427674 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT02336412 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00396461 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study NCT02839668 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02839668 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT02839668 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02839668 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03003962 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03003962 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03003962 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00389779 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00093002 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01386502 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03119493 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03119493 — Safety Biomarker (SAF): Body parameter
Study NCT02655055 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01891305 — Predictive Biomarker (PRD): CYP51A1 mRNA
Genes: CYP51A1; CYP51
Study NCT04412889 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04412889 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03122717 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03046745 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Trefoil factor 3
Genes: TFF3; ITF; TFI
Study NCT00490555 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT01387425 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT01885702 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03744221 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02333253 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01760824 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT03889392 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT03889392 — Predictive Biomarker (PRD): PKD2 mRNA
Genes: PKD2; TRPP2
Study NCT00911755 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06490575 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01435447 — Predictive Biomarker (PRD): CR2 mRNA
Genes: CR2; C3DR
Study NCT05189314 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT00384384 — Surrogate Endpoint (SUR): Serum potassium
Study NCT03808870 — Predictive Biomarker (PRD): BMX mRNA
Genes: BMX
Study NCT03808870 — Predictive Biomarker (PRD): HDAC8 mRNA
Genes: HDAC8; HDACL1; CDA07
Study NCT00498342 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00498342 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00254293 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02404519 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study NCT01800526 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03758482 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00479388 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00479388 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02317653 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03887416 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00466726 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00466726 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00466726 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00028535 — Safety Biomarker (SAF): Interleukin 12
Study NCT04143295 — Predictive Biomarker (PRD): SLC16A2 mRNA
Genes: SLC16A2; MCT7; MCT8; XPCT
Study NCT03925896 — Predictive Biomarker (PRD): PSMB9 mRNA
Genes: PSMB9; LMP2; PSMB6i; RING12
Study NCT05969444 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT01949116 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02242318 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02025075 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT04004078 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05345626 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01157715 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03447340 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01631526 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT02303314 — Predictive Biomarker (PRD): TFG mRNA
Genes: TFG
Study NCT03313882 — Predictive Biomarker (PRD): SCN5A mRNA
Genes: SCN5A
Study NCT02727270 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04259255 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04259255 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT04551820 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study NCT02125513 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT03910660 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02521818 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02631876 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT02943122 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00937651 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03812419 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02048839 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00309569 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04654676 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00599560 — Predictive Biomarker (PRD): AVPR2 mRNA
Genes: AVPR2; ADHR; DIR; DIR3; V2R
Study NCT02457975 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02457975 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04463134 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT03984747 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT00002787 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02129647 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT02439476 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT02439476 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02355756 — Pharmacodynamic Biomarker (PDY): Dermal blood flow
Study NCT04590235 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00477009 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00462943 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT04572139 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study NCT04572139 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02942056 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02942056 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT02942056 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01094249 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00109759 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT00207194 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00483587 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT00095433 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03606720 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT03216317 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04600349 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT01040663 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02263820 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04392557 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00978913 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02668822 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT00594620 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT06231459 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06231459 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04119999 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01123655 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00171093 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00171093 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03639974 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01124695 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00966043 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02547766 — Safety Biomarker (SAF): Interleukin 1
Study NCT02529306 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT02529306 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02529306 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02786719 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02180698 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT00284882 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT03661606 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02485002 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT00112749 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00112749 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03104933 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02214459 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02938520 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT02019082 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02019082 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04147819 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00650988 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT04636593 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01264640 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01264640 — Safety Biomarker (SAF): BDNF
Study NCT02340221 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT02340221 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01880827 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02591121 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT00729131 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05640128 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT03452124 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT04155359 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00057486 — Safety Biomarker (SAF): Interleukin 12
Study NCT05443100 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03697330 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00488930 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00373191 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00373191 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01663727 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01663727 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01663727 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01316419 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00197522 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03587155 — Predictive Biomarker (PRD): ASNS mRNA
Genes: ASNS; TS11
Study NCT00767520 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00913198 — Predictive Biomarker (PRD): Solute carrier family 29 member 1
Genes: SLC29A1; ENT1
Study NCT02100319 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01922934 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02947724 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02486913 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03513952 — Predictive Biomarker (PRD): IL7 mRNA
Genes: IL7
Study NCT00851149 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00447408 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00447408 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00447408 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00971737 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04412421 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00846365 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06440187 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00411398 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT02135406 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04683757 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00484419 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01514565 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT03018093 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00834041 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00834041 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03913962 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01188265 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT01740206 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03144817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04297995 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02515292 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT02515292 — Predictive Biomarker (PRD): IGF2 mRNA
Genes: IGF2; PP1446
Study NCT02760264 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03490474 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT01782339 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05077371 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02213913 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT00745888 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01861392 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03225365 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02367664 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01072786 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00036738 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00036738 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00190242 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03016338 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT05628558 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT05628558 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03349827 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03349827 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT04137549 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01934894 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02172352 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02773199 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03913234 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03913234 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03913234 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03913234 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01763918 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06711055 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02532400 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04017754 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT02280226 — Surrogate Endpoint (SUR): Blood pressure